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382 The Journal of Thoracic and Cardbjective: Intra-aortic balloon pumping in children remains a rarity. We report our
xperience in supporting pediatric cardiac surgical patients with intra-aortic balloon
umping.
ethods: We reviewed the cases of 24 children supported with intra-aortic balloon
umping after cardiac surgery in our institution from 1994 through 2003.
esults: Mean age at the time of the operation was 5.0  5.6 years (range, 7
ays-17.5 years). Ten patients were infants less than 6 months old. Mean weight was
8.9  18.1 kg (range, 3.5-58.7 kg). Indications for intra-aortic balloon pump
eployment were postoperative hemodynamic deterioration (n  11, 8 survivors),
ailure to wean off cardiopu(n 7, 5 survivors), and prophylaxis before weaning off
ardiopulmonary bypass (n  6, 5 survivors). The balloon was inserted through the
scending aorta in infants and through the femoral artery in children. Eighteen
hildren (7 infants) were weaned off the intra-aortic balloon pump successfully
intra-aortic balloon pump survival, 75%). Mean duration of intra-aortic balloon
ump support was 121.3  140.60 hours (range, 8-670 hours). There were 3
ost–intra-aortic balloon pump in-hospital deaths (survival to hospital discharge,
2.5%). Severe intra-aortic balloon pump–related complications were mesenteric
schemia in 1 patient and lower limb ischemia requiring intra-aortic balloon pump
emoval in 1 patient. At a mean follow-up of 85  31 months (range, 18-124
onths), all 15 long-term survivors were alive and well.
onclusions: Use of an intra-aortic balloon pump is an effective modality of cardiac
upport in properly selected pediatric cardiac surgical patients with refractory low
ardiac output. It can be safely used in small infants and neonates. In selected cases
ith known left ventricular dysfunction, there is a place for prophylactic use of an
ntra-aortic balloon pump.
ince its invention and introduction in clinical practice in the 1960s,1 intra-
aortic balloon pumping (IABP) has been a well-established mode of treat-
ment for acute low cardiac output syndrome and cardiogenic shock after
yocardial infarction or cardiac surgery in adults.2 However, its use in children
emains a rarity. Pollock and colleagues,3 who first described the use of IABP in
hildren in 1980, reported 80% survival in children older than 10 years but no
urvival in children younger than 5 years. The use of balloons of inappropriate size
nd “greater aortic elasticity” were thought to be the main culprits for the unsatis-
actory results in children.
Our institution does not have an extracorporeal membrane oxygenation (ECMO)
r ventricular assist device (VAD) program. Therefore we have used prolonged
onventional cardiopulmonary bypass (CPB)4 and, since 1994, IABP for cardiac
upport in children. Our initial experience (1994-1997) with 14 pediatric surgical
atients supported with IABP has been published.5 The present report summarizes
iovascular Surgery ● June 2006
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Phe 10-year experience of our institution in the use of IABP
n children undergoing cardiac surgery.
atients and Methods
e reviewed the medical records of all patients who were sup-
orted with IABP at the Royal Liverpool Children’s NHS Trust,
lder Hey Hospital, Liverpool, United Kingdom, from August
994 through December 2003. During this period, 2834 children
nderwent cardiac surgery in our institute; of these, 24 (0.84%)
equired IABP. One nonsurgical patient with dilated cardiomyop-
thy who received IABP was excluded from the study. Each
atient’s medical record was reviewed for age, body weight (BW),
iagnosis, operation or operations, inotropic support, indications
nd timing of IABP deployment, duration of support, mortality,
nd morbidity.
Age, BW, duration of IABP support, and length of stay in the
ntensive care unit (ICU) and hospital are expressed as mean
alues  standard deviation. Group comparisons were performed
ith the Student t test and the 2 test.
There were 14 (58.3%) boys. Mean age was 5.0  5.6 years
range, 7 days-17.5 years; median, 2.5 years). Mean BW was 18.9
8.1 kg (range, 3.5-58.7 kg; median, 12.3 kg). Ten (41.7%) children
ere infants (the infants group), with a mean age of 0.24 0.16 years
range, 7 days-6 months) and a mean BW of 4.2  0.7 kg (range,
.5-5.8 kg). Fourteen children were older than 22 months (the children
roup), with a mean age of 8.4 5.1 years (range, 1.8-17.5 years) and
mean BW of 29.5  17.1 kg (range, 12-58.7 kg).
The selection of the appropriate balloon catheter for our pa-
ients was based on the Datascope guidelines for pediatric balloon
izing according to age and weight (Appendix E1).6
We used a balloon volume of 2.5 mL in 10 patients (BW,
.5-5.8 kg), 5 mL in 5 patients (BW, 12-15.2 kg), 7 mL in 1 patient
BW, 18 kg), 12 mL in 3 patients (BW, 21.7-33 kg), and 34 mL in
patients (BW, 44-58.7 kg).
ndications and Timing of IABP Deployment
ll 24 patients underwent cardiac surgery for congenital heart
iseases (diagnoses and operations are summarized in Table 1).
hey were mechanically ventilated and receiving inotropic support
t the time of IABP deployment with enoximone (n  24, 100%),
Abbreviations and Acronyms
ALCAPA anomalous left coronary artery originated
from the pulmonary artery
BW  body weight
CPB  cardiopulmonary bypass
ECG  electrocardiogram
ECMO  extracorporeal membrane oxygenation
IAB  intra-aortic balloon
IABP  intra-aortic balloon pumping
ICU  intensive care unit
LV  left ventricular
PS  pulmonary stenosis
VAD  ventricular assist deviceobutamine (n  22, 91.6%), adrenaline (n  14, 58.3%), dopa- p
The Journal of Thoracicine (n 6, 25%), noradrenaline (n 3, 12.5%), and vasopressin
n  2, 8%). We consider adrenaline requirements greater than
.05 g · kg1 · min1 as a strong indication for initiating IABP.
General indications for IABP use in our institution are a patient
n a low cardiac output state (hypotension, persistent metabolic
cidosis, low urine output, and clinical evidence of poor peripheral
erfusion) that seems reversible, who had an optimal surgical
orrection of his or her heart defect and is receiving maximum
harmacologic support. Patients in a moribund condition or with a
erminal illness, severe neurologic damage, sepsis, irreparable
eart lesion, or moderate-to-severe aortic valve regurgitation are
ot considered eligible for IABP. In 13 (54.2%) patients IABP was
nitiated in the theater, whereas in 11 patients it started in the ICU
Table 2). Indications for IABP deployment were as follows:
1. Failure to wean off CPB in 8 cases: One infant with
anomalous origin of both coronaries from the pulmonary
artery continued receiving conventional CPB for circulatory
support for 154 hours before IABP insertion.
2. Prophylaxis in 5 patients in whom IABP was started before
any attempt to wean off CPB: They all had preoperatively
known poor left ventricular (LV) function caused by aortic
stenosis (n  1) or anomalous left coronary artery origi-
nating from the pulmonary artery (ALCAPA; n  4).
3. Hemodynamic deterioration postoperatively in 11 patients,
within 24 hours in 7 patients, and within 36 hours in 3
patients after admission in the ICU: The 11th patient (a
neonate after an arterial switch operation) had cardiac arrest
5 hours after his arrival in the ICU. He was transferred back
to the theater and started on conventional CPB. After 48
hours of circulatory support with CPB, IABP was deployed
for 670 hours, with an excellent outcome (long-term
survivor).
ite and Technique of Intra-aortic Balloon Insertion
he intra-aortic balloon (IAB) catheters were inserted (1) in 13
hildren through the common femoral artery (right, 8; left, 5) by
eans of direct cut-down to the artery, where the balloon was
ntroduced either directly (n  10) or through a short sleeve of a
-mm polytetrafluoroethylene graft anastomosed end to side to the
emoral artery (n  3), or (2) in all 10 infants and in the smallest
hild in our series (22-month-old; BW, 12 kg) through the ascend-
ng aorta antegradely through either the cardioplegia (n 7) or the
rterial cannula (n  2) or a separate purse-string site at the
scending aorta (n  2). The length of the IAB catheter was
remeasured on the child, and the estimated length was marked
ith a ligature. In neonates we removed the guide wire before
dvancing the catheter downward to the descending aorta because
t is guided safer and easier. The catheter was secured in place with
he purse-string suture, which was secured by a plastic snugger
xed with multiple metal clips. The sternum was left open and
tented in all 11 patients. The skin incision was covered with a
ilicone elastomer membrane. The IAB catheter exited the chest
nderneath the silicone membrane and was fixed to the skin before
eing connected to the pumping console. Particular attention was
aid to make sure that there was no tension to the IABP catheter.
n all cases a chest radiograph was taken to ascertain the IAB
osition according to standard guidelines.5,6
and Cardiovascular Surgery ● Volume 131, Number 6 1383
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1
CSPAfter minimal drain losses, the patients were started on con-
inuous heparin infusion to maintain an activated partial thrombo-
lastin time of 1.5 to 2.5 times normal value.
ABP Console
he Datascope System 97 pumping console (Datascope Medical
o Ltd, Cambridge, United Kingdom) with a pediatric volume-
imiting chamber was used in 23 patients. One patient received a
4-mL balloon, and the Datascope System 90 was used because it
as the only system available at the time. Helium gas is used for
alloon inflation/deflation because its low viscosity allows quick
neumatic response to rapid heart rates with short cardiac cycle
ime, as is the rule in children. Manual filling of the balloon is
ABLE 1. Diagnosis, operation, and outcome of children s
iagnosis Operation
. Children
Single ventricle Fontan
bidirectional Glenn
AV/MV disease AVR/MVR
TOF  pulmonary
atresia
Biventricular correction
RV-PA conduit replacement
TOF Total correction
LVOTO Resection of subvalvular
aortic membrane  IVS
ASD sec ASD closure
ubtotal I
I. Infants
ALCAPA* Reimplantation to aorta
Tunnel repair
TGA ASO
Multiple VSDs, RVOTO,
small RV
Bilateral Glenn
AVSD, small LV APW, PAB
ubtotal II
otal
ABP, Intra-aortic balloon pumping; AV, aortic valve; MV, mitral valve; AV
allot; RV, right ventricle; PA, pulmonary artery; LVOTO, left ventricular ou
LCAPA, anomalous left coronary artery originating from the pulmonary art
entricular septal defect; RVOTO, right ventricular outflow tract obstructio
indow; PAB, pulmonary artery banding. *One patient had both left and
eaned off intra-aortic balloon pumping.
ABLE 2. Indications and timing of IABP deployment
ndications Children
ailure to wean off CPB 5
rophylactically (before off CPB) 1
ostoperative hemodynamic
deterioration
8
otal 14ABP, Intra-aortic balloon pumping; CPB, cardiopulmonary bypass.
384 The Journal of Thoracic and Cardiovascular Surgery ● Junerformed every 45 to 60 minutes, unlike the adult device, which
uns on an automatic filling system. Balloon pump timing was
riggered either by the R-wave from the electrocardiogram (ECG)
r the arterial waveform (in case of arrhythmia). Balloon fre-
uency was 1:1, except during the weaning process. Augmentation
ime required manual adjustments for heart rate changes greater
han 10 beats/min to obtain optimal diastolic augmentation and
resystolic dip.
eaning Off IABP
eaning began at the physician’s discretion, when hemodynamic
tability was maintained (blood pressure normal for age, central
enous pressure 10 mm Hg, left atrial pressure 10 mm Hg, urine
rted with IABP
No. of
atients
Weaned off
IABP
Discharged from
hospital
Long-term
survivors
5 4 2 2
1 0  
3 3 3 3
1 1 1 1
1 0  
1 1 1 1
1 1 1 1
1 1 1 1
14 11 (78.6%) 9 (64.3%) 9 (64.3%)
5* 4 4 4
1 1 1 1
2 1 1 1
1 0  
1 1 0 
10 7 (70%) 6 (60%) 6 (60%)
24 18 (75%) 15 (62.5%) 9 (62.5%)
rtic valve replacement; MVR, mitral valve replacement; TOF, tetralogy of
tract obstruction; IVS, interventricular septum; ASD, atrial septal defect;
A, transposition of the great arteries; ASO, arterial switch operation; VSD,
D, atrioventricular septal defect; LV, left ventricle; APW, aortopulmonary
coronary arteries originating from the pulmonary artery; he could not be
Infants Total (%)
Weaned off
IABP (%)
2 7 (29.1) 5 (71.4)
5 6 (25) 5 (83.3)
3 11 (45.8) 8 (72.7)
10 24 18 (75)uppo
p
R, ao
tflow
ery; TG
n; AVS
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Putput 2 mL · kg1 · h1, periphery-to-core difference in tempera-
ure 2°C, and no metabolic acidosis), and inotropic support was
inimal (enoximone  dobutamine 5 g · kg1 · min1). Two-
imensional echocardiography was used to aid in the decision to
ean. Improvements in the LV performance and its indices (shorten-
ng fraction and ejection fraction) were used as guidelines. The
eaning procedure in our institution has been described previously.6
n brief, as a first step, the augmentation was gradually reduced to
0%. If this was tolerated for 4 to 6 hours, balloon frequency was
educed from 1:1 to 1:2 for 3 to 4 hours and then to 1:3 for 2 to 3
ours. The weaning procedure usually took 10 to 24 hours, depending
n the status of the patient.
emoval of the Balloon
n case of direct cut-down of the femoral artery, the skin incision
as reopened, the balloon was removed, and the exit at the artery
as closed by means of direct suturing. If a side graft was used, the
alloon was removed through the graft, which was doubly ligated
ith clips and cut off, leaving a small stump at the site of the
rterial anastomosis. In case of insertion through the ascending
orta, through the open chest, the deflated balloon was carefully
emoved from the ascending aorta, while the purse-string suture
as tightened down, closing the entrance hole. A mattress suture
as placed at the insertion site for safety.
ollow-up
ll long-term survivors were followed up in the outpatient clinic
ith clinical examination and echocardiography.
esults
ortality
able 3 summarizes survival and mortality in our series.
ighteen (75%) patients were successfully weaned off
ABP. Successful weaning was 78.5% in children and 70%
n infants (P  .27). Age was not a risk factor for mortality
fter IABP support.
The mean BW of infants who died on IABP support was
.8 kg and that of those who survived was 4.3 kg (P 
269). The mean BW of children who died on IABP support
as 42.6 kg versus 25.9 kg of survivors (P  .069). Hence
W was not a risk factor to successful weaning off IABP.
There were 2 neonates in our series (a 7-day-old and a
ABLE 3. Mortality of pediatric IABP
atients weaned off IABP
ost-IABP in-hospital deaths
IABP-related deaths (mesenteric ischemia)
ABP survivors
arly survivors (patients discharged from hospital)
ong-term survivors
ABP, Intra-aortic balloon pumping.9-day-old) with transposition of the great arteries who had b
The Journal of Thoracicn arterial switch operation. The former patient was weaned
ff CPB on IABP and a strong inotropic support. He had a
lobal LV dysfunction and died 8 hours after surgical in-
ervention. The latter patient was supported with IABP and
as successfully weaned off after 670 hours of support,
ecoming a long-term survivor.
Concerning the timing of IABP deployment, survival
as best among patients with IABP started prophylactically
n the theater before attempting to wean off CPB (5/6
83.3%]). The patient in this group who died despite the
rophylactic insertion of an IABP (a 52-day-old female
eighing 3.5 kg) had both coronaries originating from the
ulmonary artery and a very poor ventricular performance
ecause of extensive myocardial infarction. She was sup-
orted for only 8 hours before she died. Survival was poorer
n patients with the IABP placed in the ICU (8/11 [72.7%]),
s well as in patients who failed to wean off CPB before
ABP initiation (5/7 [71.4%]), but these differences did not
each statistical significance.
The duration of IABP support ranged from 8 to 670
ours (mean, 121.3 140.60 hours) for the whole series. In
nfants the mean IABP duration was 152.7  196.39 hours
median, 106 hours; range, 8-670 hours) and in children it
as 97.3  86.70 (median, 60 hours; range, 12-260 hours;
 .37).
Patients who died on IABP support were supported for a
ean of 18.8  10.55 hours (range, 8-36 hours), whereas
urvivors of IABP were supported for a mean 155.6 
47.54 hours (range, 12-670 hours; median, 120 hours; P 
001). Patients who died were so severely sick that there was
o time for the IABP to offer any help (all died within 48
ours after the operation).
Of the 18 patients who were weaned off IABP, 3 (2
hildren and 1 infant) died before discharge from the hos-
ital (short-term survivors). One child (5.3-year-old female;
W, 12.6 kg; diagnosis: “single-ventricle physiology,”
trial isomerism, common atrium, double-outlet right ven-
ricle, transposition of the great arteries, atrioventricular
eptal defect, and pulmonary stenosis [PS]; status after
Children
(n  14)
Infants
(n  10)
Total
(n  24)
1 (78.5%) 7 (70%) 18 (75%)
2 1 3
1 0 1
0 (71.4%) 7 (70%) 17 (70.8%)
9 (64.3%) 6 (60%) 15 (62.5%)
9 (64.3%) 6 (60%) 15 (62.5%)1
1ilateral bidirectional Glenn shunt) had completion of the
and Cardiovascular Surgery ● Volume 131, Number 6 1385
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CSPontan procedure and was supported for 190 hours with
ABP. Five days after successful weaning, she underwent
xploratory laparotomy for peritonitis caused by mesenteric
nfarction and ischemic colitis. Colectomy with ileostomy
as performed. She was re-explored 7 days later because of
eritoneal abscess and died of sepsis 34 days after success-
ul weaning off IABP.
The second child (2.5-year-old male; BW, 14 kg; diag-
osis: tricuspid atresia, ventricular septal defect, and PS;
revious modified Blalock-Taussig shunt) underwent a Fon-
an operation and was supported with IABP for 250 hours.
e was successfully weaned off IABP but died 6 weeks
ater during the same hospitalization caused by extensive
hrombosis of the superior vena cava and jugular veins.
The third short-term survivor was an infant (4.5-month-
ld male; BW, 4.5 kg) with “complete atrioventricular sep-
al defect, common atrioventricular valve, and small left
entricle” submitted to pulmonary artery banding and aor-
opulmonary window. He was supported with IABP for 244
ours and was successfully weaned off. His postoperative
ourse was complicated with temporary absent foot pulse,
ransient arrhythmia, and respiratory infection. He died of
espiratory syncytial virus infection 31 days after weaning
ff IABP.
orbidity
he complications observed in our patients can be arbi-
rarily be divided into 3 groups (Table 4):
1. IABP-related complications (n  4 in 3 children):
One patient (described in the “Mortality” section)
ABLE 4. Morbidity of pediatric IABP
omplications
Childre
(n  1
ABP related 4
Mesenteric ischemia/enterectomy 1 (1)
Lower limb ischemia, femoral
arterioplasty
1 (1)
Temporary foot pulse loss 2
eparin related 2
Bleeding/chest re-exploration 1
Thrombocytopenia 1
Hemopericardium/tamponade 0
ther 3
Sepsis 2
SVC thrombosis 1 (1)
Pericardial effusion 0
Recurrent pneumothoraces 0
Arrhythmia 0
LV clot 0
otal complications/patients 9/7 (50
The number of patients who died is shown in parentheses.had mesenteric ischemia discovered 5 days after suc-
386 The Journal of Thoracic and Cardiovascular Surgery ● Juncessful weaning off IABP. The balloon should be
credited for this fatal complication. Some abdominal
tenderness and distension noticed 3 days after IABP
removal should have alerted the attending physicians,
and possibly this death could have been prevented.
This patient had also loss of right foot pulses, which
returned after hemodynamics improved, without any
other signs of limb ischemia. Chest radiography con-
firmed the balloon was placed above L1. Another
patient (17.5 years old, submitted to right ventricle–
to–pulmonary artery conduit replacement and left
pulmonary artery stent dilatation) had leg ischemia
after 36 hours of IABP support, necessitating IAB
catheter removal, femoral arterioplasty, and leg fas-
ciotomy. The IAB was reinserted through the con-
tralateral femoral artery. The patient died after 24
hours as a result of low cardiac output syndrome. A
third patient (16 years old) had temporary foot pulse
loss with mild limb ischemia not requiring IAB re-
moval.
2. “Heparin-related” complications: Bleeding was the
most common complication, necessitating chest ex-
ploration in 3 patients (3 times in one of them).
Hemopericardium causing tamponade was the reason
for chest opening in another case. In no case was
bleeding related to the IAB insertion site.
3. Other complications: Sepsis was present in 3 patients
(2 children and 1 infant) with fever (temperature
38.5°C for more than 2 days) and positive blood
Infants
(n  10) Total (n  24)
0 4
 1 (1)
 1 (1)
 2
4 6
2 3
1 2
1 (1) 1 (1)
5 8
1 3
0 1 (1)
1 1
1 1
1 1
1 1
9/6 (60%) 18/13 (54.1%)n
4)
*
%)cultures requiring change of our standard antibiotic
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Pprotocol. Five additional patients had fever lasting
less than 2 days and without positive blood cultures.
No evidence of mediastinitis occurred in the 11
patients with the IABP inserted through the ascend-
ing aorta and the chest left open.
One child had severe chronic lung disease preoperatively
ith multiple congenital lung bullae and postoperatively
equired ventilation with high-flow oscillation for hypercar-
ia. He had repeated loculated pneumothoraces requiring
nsertion of intrathoracic tubes 7 times.
One infant was given a diagnosis of a clot in the left
entricle, which was dissolved after 3 days of formal anti-
oagulation therapy. Another infant experienced refractory
rrhythmia requiring amiodarone infusion for 2 days imme-
iately after surgical intervention.
Renal function was compromised in no case; on the
ontrary, urine output greatly increased after IABP institu-
ion, and in 5 cases the peritoneal dialysis instituted before
ABP was discontinued.
Eleven patients (10 infants and 1 child) had the chest left
pen after surgical intervention. The IABP survivors had
heir chests closed after 5.9 to 28 days (median, 7 days).
either sternal wound infection nor mediastinitis was no-
iced in the patients with a delayed chest closure.
The IABP survivors were mechanically ventilated for a
edian duration of 144 hours (range, 7-1370 hours); their
edian ICU stay was 12 days (range, 5-67 days), and the
edian total hospital stay was 21 days (range, 11-127 days).
ollow-up Results
ll 15 discharged patients were followed up with regular
linical and echocadiographic assessment. They have all
een alive and well for a mean of 7.1 years (range, 1.7-10.3
ears). All have improved to normal ventricular function.
ne patient, a 4.3-month-old infant with ALCAPA syn-
rome who underwent intrapulmonary tunnel repair (Takeu-
hi procedure), showed evidence of PS on the echocardio-
ram performed on the 81st postoperative day. She had to
ndergo reoperation 5 months after the initial operation for
elief of tunnel stenosis and supravalvular PS. At present (8
ears after reoperation), she has persistent mild PS (pressure
ABLE 5. Literature review of pediatric IABP
ear Author Center
980 Pollock and coworkers3 Toronto, Canada 
983 Veasy and coworkers8 Salt Lake City, Utah 
985 Webster and Veasy10 Salt Lake City, Utah 
999 Acomea-Agyin and coworkers5 Liverpool, United Kingdo
002 Pinkney and coworkers11 Salt Lake City, Utah 
006 Present series Liverpool, United Kingdo
The total number of patients (surgical and medical) is shown in parenthradient, 30 mm Hg). a
The Journal of Thoraciciscussion
ABP has been routinely used in adults with LV failure.
owever, its use in small children and infants has not been
idespread, although today the pediatric balloon catheters
nd pumping consoles have been greatly evolved, there are
ommercially available devices suitable for even the small-
st child, and the early concerns about the elasticity and
istensibility of the pediatric aortic wall on the effectiveness
f the counterpulsation have proved ungrounded.7,8 The
ajor reason for this is the fact that children with congenital
eart disease usually have biventricular dysfunction and
mpaired pulmonary function (pulmonary hypertension).
CMO provides support of both the systemic and pulmo-
ary ventricles and circulations. VADs are limited to sup-
ort the ventricles. IABP supports both ventricles (increas-
ng the diastolic pressure and perfusing the coronary arteries
y means of balloon inflation) but mainly the left ventricle
reducing afterload during LV ejection by means of balloon
eflation). ECMO and VADs are today the most prevalent
eans of mechanical circulatory assistance for children
ith congenital heart disease.
Necessity is the mother of invention, and because our
nstitution has no ECMO or VAD program, it forced us to
se IABP in children for more than a decade. The present
eport chronicles the largest pediatric IABP experience in
ardiac surgical patients. To the best of our knowledge, our
eries comprises the youngest patients and the patients with
he smallest BW in the world literature who survived IABP.
The 75% survival (ie, successful weaning off) after IABP
upport in our series compares favorably with the reported
urvival in adults, as well as with that seen in other pediatric
eries (Table 5).3,5,9-11
Infants tend to do worse than children on IABP (IABP
urvival: 70% vs 78.5%, respectively, in our series).
inkney and associates11 reported survival of 50% (4/8) in
nfants versus 66.7% (14/21) in children older than 1 year.
owever, as in our series, the difference in survival between
nfants and children was not statistically significant.
Although IABP is a quite different modality of mechan-
cal circulatory support compared with ECMO, VADs, or
oth, we would attempt a rough comparison of their char-
Surgical
patients Age range BW (kg)
Weaned off
IABP (%)
Discharged from
hospital (%)
14 1.5-18 y 8-52 8 (57) 6 (42.8)
8 6 wk-6.1 y 4.2-16 4 (50) 2 (25)
6 (18*)† 5 d-11.8 y 3.1-33.2 7 (44) 4 (25)
14 7 d-13 y 3.5-51 10 (71) 8 (57.1)
6 (29*) 1.7 m-18.5 y 4.3-56 9 (60) 9 (60)
24 7 d-17.5 y 3.5-58 18 (75) 15 (62.5)
†Included are the 8 patients reported by Veasy and coworkers.91
m 
1
mcteristics and results (Table E1).
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CSPSurvival of patients with congenital heart disease under-
oing ECMO (according to the Extracorporeal Life Support
rganisation registry12) ranged from 36% (neonates, up to
0 days) to 40% (children, 1-16 years) and 42% (infants, 31
ays-1 year). In 2 recent single-center studies, survival of
ediatric cardiac surgical patients admitted to the ICU was
0%.13,14
Survival after LV assist device support in the series by
el Nido and coworkers15 was 71% (5/7) in infants with
LCAPA syndrome and severely compromised LV func-
ion. It is worth noting that all 5 survivors required re-
xploration for bleeding from the cannulation site.
The Extracorporeal Life Support Organisation Registry
eport Data (July 2004) on patients started on some form of
xtracorporeal life support (with ECMO or VADs) show a
8% survival of the extracorporeal life support and 43%
urvival to discharge from hospital or transfer to transplan-
ation in children (57% and 38% in neonates, respective-
y).16 These results are definitely no better than those
chieved with the IABP support.
The timing of IABP in our series ranged from before
eaning off CPB up to 7 days postoperatively, highlighting
he difficulty in decision making. The most important index
s the clinical judgment of the surgeon on LV performance.
n our series we have introduced IABP insertion before
ttempting to wean off CPB in cases involving preopera-
ively known poor LV function, as in patients with
LCAPA syndrome.17 Our first patient with ALCAPA syn-
rome was easily weaned off CPB after repair but 36 hours
ater had clinically and hemodynamically deteriorated and
ad to be started on IABP with a good and prompt response.
ince then, we have started all our patients with ALCAPA
yndrome on IABP before attempting to wean them off
PB.6 The results (survival, 83.3% [5/6]) justified this ag-
ressive policy. Of course, not all patients with ALCAPA
yndrome need IABP support, but we would recommend
rophylactic use of IABP in patients with preoperatively
nown severe LV dysfunction, using as criteria the degree
f LV dilatation and the grade of the subsequent mitral
alve regurgitation, as well as the clinical status of the
atient.
Initiation of IABP in the theater, before attempting to
ean off CPB, seemed to result in a better, although not
tatistically significant, survival in our series when com-
ared with initiation after failure to wean off CPB or in the
CU. Chaturvedi and associates13 also noticed a better sur-
ival when ECMO was begun in the theater than in the ICU
64% vs 29%, respectively), whereas Morris and cowork-
rs14 reported no difference.
In our series we used standard ECG timing methods for
ABP inflation and deflation. Pinkney and associates11 have
sed an echocardiographic timing technique as a more ac-
urate method of balloon timing with aortic valve closure c
388 The Journal of Thoracic and Cardiovascular Surgery ● Junnd opening. Although there is a theoretic background in the
oncept of the echo-timing technique (radial artery tracing
ight deviate up to 120 ms from the central aortic pressure
racing), the method of IABP timing does not seem to make
difference in the effectiveness of IABP support because in
he above-mentioned report it is stated that “survival was
ot statistically better in the echocardiography-time era as
ompared with the standard ECG triggered timing era.” We
ad no major problems in effectively supporting our pa-
ients with the ECG-triggered timing method, and our re-
ults confirm this.
In our early experience we have used IABP after the
ontan (or Glenn) procedure, but it was followed by a high
ncidence of failure to retrieve poor ventricular function: 4
57%) of 7 patients were weaned off IABP (3 [43%] were
ischarged from the hospital). Similar experience has been
eported by others11,18-20: of 16 patients undergoing the
ontan procedure, only 4 (25%) were successfully weaned
ff IABP. Pinkney and associates11 recommend that “IABP
hould be used in this group only when the patient has
rimarily ventricular dysfunction rather than the low cardiac
utput state typically seen due to Fontan physiology. . ..”
heoretically, IABP might benefit the single-ventricle phys-
ology by reducing afterload and end-diastolic and filling
ressures of the single ventricle. In fact, IABP seems not to
e as beneficial as expected in the Fontan procedure, pos-
ibly because the causes of failure in Fontan physiology are
ultiple (eg, long-standing ventricular volume overload,
ncreased pulmonary vascular resistance, and residual car-
iac defects). We have abandoned the deployment of IABP
or support of patients undergoing the Fontan procedure for
everal years. Our practice is that if the Fontan procedure
oes not work, we take it down and go back to the previous
tage of bidirectional Glenn shunt.
Complications from IABP did appear in 3 patients in our
eries (in 2 they were severe). Others have reported no
ajor complications caused by IABP resulting in fatality or
ABP removal.9-11 We had no complications in infants, in
hom the balloon was inserted through the ascending aorta
ithout the guide wire.
In conclusion, IABP has been proved to be an effective
nd life-saving adjunct to conventional medical treatment
or cardiac support in properly selected pediatric cardiac
urgical patients with refractory low cardiac output. Al-
hough not a substitute for ECMO or VADs, in centers with
imited resources (eg, those in emerging countries), IABP
an be an alternative for effective mechanical circulatory
upport. It can be used in children of all ages and, in fact, of
ll BWs with safety and with satisfactory early and long-
erm results. In neonates and small infants IAB insertion
hrough the ascending aorta eliminates the risk of compli-
ations. In selected patients with preoperatively known se-
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CSPABLE E1. Comparison of the 3 main modalities for acute circulatory support in children with congenital heart defects:
CMO, centrifugal VAD, and IABP
haracteristic ECMO VAD IABP
iventricular support Yes Possible No
pen sternum No Yes No (yes, in neonates/small infants)
nticoagulation Yes (180-250) Yes (160-200) Usual, not necessary
omplications Moderate Lower Lowest
leeding Moderate Higher Lowest
ase of use High Lower Low
uration of support Days to weeks Days to weeks Days to weeks
ost High Lower Lowest
urvival to hospital discharge 36%-40%* 30%-40%† 60%-62%‡
CMO, Extracorporeal membrane oxygenation; VAD, ventricular assist device; IABP, intra-aortic balloon pumping. *Chaturvedi and coworkers.13 †Cohen
nd Permut.16 ‡Derived from Pinkney and coworkers11 and the present series.
ppendix E1. Pediatric IAB specifications
ge of
atient
y)
Weight of
patient
(kg)
IAB
volume
(mL)
Stroke
volume
(mL)
Catheter
size (F)
IAB
length
(cm)
IAB
diameter
(mm)
IAB
preload
(mL)
1 3-8 2.5 5-10 4.5 10.7 6.0 6
-2.5 8-13 5.0 10-18 5.5 12.8 8.0 10
.6-5 13-18 7.0 18-28 5.5 14.2 9.0 12
-12 18-40 12.0 28-68 7.0 17.8 10.0 17
12 40 20.0 68-90 7.0 19.4 12.0 26AB, Intra-aortic balloon.
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